← Back to the chain

Recurance · prevention of future deaths reports

Pre-inquest brief

Ketamine use risks insufficiently recognised

Organisation: Department of Health and Social Care · Generated: 26 Oct 2026

Recurance · recurance.com/chains/9b5fd08448119d7c

The earlier warning

Gemma Weeks · 19 Aug 2025 · Brendan Allen, Dorset

“Ketamine is a controlled drug of class B. There is a perception in naïve users that this signifies "lesser" risks associated with using ketamine as compared with class A drugs.”

judiciary.uk/…/gemma-weeks-prevention-of-future-deaths-report

What was promised

A published response was found, but no specific action could be extracted with a verified quote.

What recurred

  • 18 Jun 2026 · Isabelle Bridie Sapherson-Moralee · Brendan Joseph Allen · Closely related · confidence 0.90 (high)

The clearest link, quoted from both reports:

Earlier · Gemma Weeks · 19 Aug 2025

“Ketamine is a controlled drug of class B. There is a perception in naïve users that this signifies "lesser" risks associated with using ketamine as compared with class A drugs.”

Later · Isabelle Bridie Sapherson-Moralee · 18 Jun 2026

“There is limited research on the addictiveness of ketamine and the consequences of chronic ketamine use.”

What happened next

No web check of the stated actions has been published for this chain.

Every quote is verified word for word against the original report on judiciary.uk. A link shows that a similar concern was raised again, not why. It is not a finding about any organisation or person.

Source: Courts and Tribunals Judiciary, Open Government Licence v3.0.